| Literature DB >> 28820717 |
Alinune N Kabaghe1,2, Michael G Chipeta3,4,1, Dianne J Terlouw3,1,5, Robert S McCann1,6, Michèle van Vugt2, Martin P Grobusch2, Willem Takken6, Kamija S Phiri1.
Abstract
In stable transmission areas, malaria is the leading cause of anemia in children. Anemia in children is proposed as an added sensitive indicator for community changes in malaria prevalence. We report short-term temporal variations of malaria and anemia prevalence in rural Malawian children. Data from five repeated cross-sectional surveys conducted over 1 year in rural communities in Chikwawa District, Malawi, were analyzed. Different households were sampled per survey; all children, 6-59 months, in sampled household were tested for malaria parasitemia and hemoglobin levels using malaria rapid diagnostic tests (mRDT) and Hemocue 301, respectively. Malaria symptoms, recent treatment (2 weeks) for malaria, anthropometric measurements, and sociodemographic details were recorded. In total, 894 children were included from 1,377 households. The prevalences of mRDT positive and anemia (Hb < 11 g/dL) were 33.8% and 58.7%, respectively. Temporal trends in anemia and parasite prevalence varied differently. Overall, unadjusted and adjusted relative risks of anemia in mRDT-positive children were 1.31 (95% CI: 1.09-1.57) and 1.36 (1.13-1.63), respectively. Changes in anemia prevalence differed with short-term changes in malaria prevalence, although malaria is an important factor in anemia.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28820717 PMCID: PMC5817775 DOI: 10.4269/ajtmh.17-0335
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Summary statistics for participants and prevalence of anemia (Hb < 11 g/dL)
| Characteristic | Factor | Total (%) | Anemia | |
|---|---|---|---|---|
| Total number of children | – | 894 | 525 (58.7) | – |
| Sex | Male | 452 (50.6) | 254 (48.4) | 0.120 |
| Female | 442 (49.4) | 271 (51.6) | ||
| Age category in months | 6–11.9 | 100 (11.2) | 84 (84.0) | < 0.001 |
| 12–23.9 | 201 (22.5) | 129 (64.5) | ||
| 24–35.9 | 230 (25.7) | 136 (59.1) | ||
| 36–47.9 | 174 (19.4) | 97 (55.6) | ||
| 48–59.9 | 190 (21.2) | 79 (41.6) | ||
| Household owns at least one ITN (%) | Yes | 323 (36.1) | 191 (59.1) | 0.819 |
| No | 569 (63.6) | 332 (58.4) | ||
| WHZ | < −2 SD | 182 (20.4) | 107 (58.8) | 0.964 |
| ≥ −2 SD | 703 (78.6) | 412 (58.6) | ||
| HAZ | < −2 SD | 394 (44.1) | 242 (61.4) | 0.139 |
| ≥ −2 SD | 499 (55.8) | 282 (56.5) | ||
| mRDT | Positive | 302 (33.8) | 223 (73.8) | < 0.001 |
| Negative | 592 (66.2) | 302 (57.0) | ||
| Severe anemia | – | 37 (4.1) | – | – |
| Mean | 95% confidence interval | – | – | |
| Hemoglobin in g/dL | 10.5 | 10.3–10.7 | – | – |
HAZ = height-for-age z score; Hb = hemoglobin; ITN = insecticide-treated bed net; mRDT = malaria rapid diagnostic test; SD = standard deviation; WHZ = weight-for-age z score.
Missing data for some children. The following were denominators: household owns at least one ITN (N = 892); WHZ (N = 885); HAZ (N = 893).
Figure 1.Symptomatic and asymptomatic malaria. The flow diagram shows symptomatic and asymptomatic mRDT-positive patients based on the presence/absence of malaria symptoms and recent malaria treatment. a mRDT positive without prior malaria treatment in past 2 weeks; b mRDT positive from presumed residual antigens in blood and not active infection, based on antimalaria treatment in previous 2 weeks; c Malaria symptoms during the survey were either one or both of the following 1) confirmed fever (axillary temperature of 37.5°C or above) and 2) reported fever within the past 48 hours. mRDT = malaria rapid diagnostic test.
Figure 2.Graph for mean hemoglobin (mg/dL) by mRDT category. Children with negative mRDT results had higher hemoglobin level compared with those with an mRDT-positive result. mRDT = malaria rapid diagnostic test; CI = confidence interval.
Figure 3.Proportion of parasitemic and anemic children by age group.
Rainfall, temperature, anopheline density and prevalence of anemia, malaria parasitemia and malnutrition in children < 5 years by sampling round
| Year | 2015 | 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Months | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Jan | Feb | Mar |
| Sampling rounds | 1 ( | 2 ( | 3 ( | 4 ( | 5 ( | ||||||
| Average temperature in degrees Celsius | 22.3 | 20.8 | 24.5 | 30.1 | 28.4 | ||||||
| Total rainfall in mm | 12.0 | 0 | 0 | 17.0 | 57.2 | ||||||
| Mean anopheles mosquito density | 0.13 (0.04–0.23) | 0.27 (0.19–0.35) | 0.17 (0.10–0.24) | 0.11 (0.04–0.19) | 0.07 (0.03–0.10) | ||||||
| Any anemia – Hb < 11 g/dL; % (95% CI) | 58.9 (52–66) | 58.2 (51–65) | 73.7 (67–80) | 48.0 (40– 55) | 54.7 (47–62) | ||||||
| Severe anemia – Hb < 7 g/dL; % (95% CI) | 3.2 (1.5–7.1) | 2.1 (0.8–5.7) | 15.4 (10.7–21.5) | 0 | 0 | ||||||
| Total mRDT positive; % (95% CI) | 36.8 (29.8–43.7) | 47.3 (40.0–54.5) | 43.4 (36.1–50.8) | 28.0 (21.3–34.8) | 13.3 (8.3–18.2) | ||||||
| Untreated mRDT positive; % (95% CI) | 27.6 (21.1–34.0) | 40.1 (32.8–47.0) | 35.4 (28.3–42.5) | 25.1 (18.6–31.7) | 11.0 (6.5–15.6) | ||||||
| Asymptomatic untreated mRDT positive; % (95% CI) | 10.3 (5.9–14.6) | 17.5 (12.0–23.0) | 25.1 (18.7–31.6) | 17.5 (11.8–23.2) | 6.6 (3.0–10.3) | ||||||
| HAZ < −2; | 41 (22.2) | 44 (24.2) | 47 (26.9) | 40 (23.4) | 23 (12.7) | ||||||
| WHZ < −2; | 20 (10.8) | 20 (11.0) | 11 (6.3) | 23 (13.5) | 21 (11.6) | ||||||
HAZ = height-for-age z-score (stunting); WHZ = weight-for-height z-score (wasting); mRDT = malaria rapid diagnostic test.
Total Anopheles females collected per house per night regardless of whether sampling was done indoors or outdoors.
Nine children and one child had incomplete data for WHZ and HAZ, respectively, and were excluded from the denominator.
Figure 4.Anemia and parasitemia by sampling round.
The unadjusted and adjusted relative risks of anemia in children with mRDT-positive result by sampling round
| Round | 1 | 2 | 3 | 4 | 5 | Overall |
|---|---|---|---|---|---|---|
| Unadjusted relative risk (95% CI) | 1.19 (0.78–1.77) | 1.28 (0.87–1.88) | 1.32 (0.92–1.87) | 1.28 (0.78–2.04) | 1.33 (0.72–2.27) | 1.31 (1.09–1.57) |
| Adjusted | 1.31 (0.84–2.02) | 1.29 (0.87–1.89) | 1.31 (0.91–1.88) | 1.52 (0.90–2.54) | 1.31 (0.71–2.26) | 1.36 (1.13–1.63) |
Adjusted for age, weight-for-height, and height-for-age.